Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis
Endocrinology, Diabetes & Metabolism Case Reports · 01.04.2023 · 2023 (2)
DOI: 10.1530/edm-22-0352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism Case Reports, erschienen am 01.04.2023. Verfasst von Taieb Ach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, University Hospital of Farhat Hached Sousse, Tunisia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive inherited syndrome caused by mutations in autoimmune regulator ( AIRE ) gene. The three clinical components of this syndrome are mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency. In addition to these frequent symptoms, many other components have been reported including gastrointestinal manifestations.We report a case of a 17-year-old Caucasian female patient diagnosed with APECED who presented with acute abdominal pain. Her medical history revealed chronic digestive discomfort without bowel movement disorders. The patient needed a significant increase in doses of calcium supplementation and hydrocortisone which appeared to be partially inefficient. Investigation with esophagogastroduodenoscopy and biopsy showed autoimmune atrophic gastritis. The patient eventually needed increasing doses of treatment received in order to achieve desired clinical and biological therapeutic goals. Learning points Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive inherited syndrome caused by mutations in the autoimmune regulator ( AIRE ) gene. The three clinical components of this syndrome that appear in early childhood are mucocutaneous candidiasis, hypoparathyroidism, and primary adrenal insufficiency. In addition to these frequent symptoms, many other components have been reported including gastrointestinal manifestations like atrophic gastritis. They can be caused by many abnormalities including atrophic gastritis and the modification of intestinal biofilm and microbiota. Early diagnosis and treatment of gastrointestinal manifestations associated with APECED prevent multiple life-threatening consequences like acute adrenal crisis and severe symptomatic hypocalcemia.
Autor:innen und Institutionen
- Department of Endocrinology, University Hospital of Farhat Hached Sousse, Tunisia.
- University of Sousse, Faculty of Medicine of Sousse, Sousse, Tunisia.
- University of Tunis, Faculty of Medicine of Tunis, Tunis, Tunisia.
- Department of Dermatology, University Hospital of Farhat Hached Sousse, Tunisia.
ORCID-Profile: Taieb Ach
Zitieren
APA
Ach, T., Hadami, B. Y., Ghariani, N., Said ElMabrouk, R., Ben Abdelkrim, A., Kacem, M., Denguezli, M., & Ach, K. (2023). Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis. Endocrinology, Diabetes & Metabolism Case Reports, 2023(2). https://doi.org/10.1530/edm-22-0352
Vancouver
Ach T, Hadami BY, Ghariani N, Said ElMabrouk R, Ben Abdelkrim A, Kacem M, et al. Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis. Endocrinology, Diabetes & Metabolism Case Reports. 2023;2023(2). doi:10.1530/edm-22-0352
BibTeX
@article{Ach2023,
author = {Ach, Taieb and Hadami, Ben Yamna and Ghariani, Nadia and Said ElMabrouk, Randa and Ben Abdelkrim, Asma and Kacem, Maha and Denguezli, Mohamed and Ach, Koussay},
title = {Gastrointestinal manifestations in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patient: major effect on treatment and prognosis},
journal = {Endocrinology, Diabetes & Metabolism Case Reports},
year = {2023},
volume = {2023},
number = {2},
doi = {10.1530/edm-22-0352}
}
EUVIMED